Morna Dorsey, MD, MS

My research interests lie in three main focus areas:

1. Optimizing diagnosis and care of patients with primary immunodeficiency
2. Investigating the psychosocial impact of primary immunodeficiency on patients and families
3. Establishing treatment for patients with food allergy and eosinophilic disorders
Publications
  1. Eczema and Petechiae in an Infant.
  2. Correction to: Infections in Infants with SCID: Isolation, Infection Screening and Prophylaxis in PIDTC Centers.
  3. When Screening for Severe Combined Immunodeficiency (SCID) with T Cell Receptor Excision Circles Is Not SCID: a Case-Based Review.
  4. Unknown cytomegalovirus serostatus in primary immunodeficiency disorders: A new category of transplant recipients.
  5. Folliculotropic mycosis fungoides driven by DOCK8 immunodeficiency syndrome.
  6. Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.
  7. Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases.
  8. Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.
  9. Lentiviral gene therapy for X-linked chronic granulomatous disease.
  10. Extended Follow-up After Hematopoietic Cell Transplantation for I?Ba Deficiency with Disseminated Mycobacterium avium Infection.
  11. Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: A working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology.
  12. TASP1 mutation in a female with craniofacial anomalies, anterior segment dysgenesis, congenital immunodeficiency and macrocytic anemia.
  13. Low Exposure Busulfan Conditioning to Achieve Sufficient Multilineage Chimerism in Patients with Severe Combined Immunodeficiency.
  14. Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017.
  15. Outcomes for Nitazoxanide Treatment in a Case Series of Patients with Primary Immunodeficiencies and Rubella Virus-Associated Granuloma.
  16. AR101 Oral Immunotherapy for Peanut Allergy.
  17. Newborn Screening for Severe Combined Immunodeficiency in the United States: Lessons Learned.
  18. Supporting caregivers during hematopoietic cell transplantation for children with primary immunodeficiency disorders.
  19. Neurologic event-free survival demonstrates a benefit for SCID patients diagnosed by newborn screening.
  20. Newborn Screening for Severe Combined Immunodeficiency in the US: Current Status and Approach to Management.
  21. Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening.
  22. Gastrointestinal Manifestations in X-linked Agammaglobulinemia.
  23. Update on the use of immunoglobulin in human disease: A review of evidence.
  24. Longstanding Eosinophilia in a Case of Late Diagnosis Chronic Granulomatous Disease.
  25. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.
  26. Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency.
  27. Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiency.
  28. Clinical experience with an L-proline–stabilized 10 %intravenous immunoglobulin (Privigen®): real-life effectiveness and tolerability.
  29. Alterations in regulatory T cell subpopulations seen in preterm infants.
  30. Chronic granulomatous disease associated colitis leading to profound zinc deficiency.
  31. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.
  32. Intensive educational course in allergy and immunology.
  33. FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.
  34. Complete DiGeorge syndrome associated with CHD7 mutation.
  35. Impaired specific antibody response and increased B-cell population in transient hypogammaglobulinemia of infancy.
  36. Assessment of adrenal suppression in children with asthma treated with inhaled corticosteroids: use of dehydroepiandrosterone sulfate as a screening test.
  37. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition.
  38. Mutations in the iron-sulfur cluster ligands of the human ferrochelatase lead to erythropoietic protoporphyria.